Phase 2 Trial of BMF-219 in Participants With Type 1 Diabetes Mellitus
Trial details
- Registry ID
- NCT06152042
- Phase
- Phase 2
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Phase 2 Trial of BMF-219 in Participants With Type 1 Diabetes MellitusNCT06152042 | BMEA | Phase 2 | Completed | 2025-05-20Actual |
| Study of BMF-219 in Healthy Adult Subjects and in Adult Subjects With Type 2 Diabetes Mellitus (T2D)NCT05731544 | BMEA | Phase 1, Phase 2 | Completed | 2024-11-18Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |